Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-03-01
2011-03-01
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07897577
ABSTRACT:
The present invention is directed to a reconstituted surfactant containing a lipid carrier, a polypeptide analog of the native surfactant protein SP-C, and a polypeptide comprising a sequence comprised of repeated units where each unit contains between 3 and 8 hydrophobic amino acid residues and one basic amino acid residue. The invention is also directed to the pharmaceutical compositions thereof and to its use for the prophylaxis and/or treatment of RDS and other respiratory disorders.
REFERENCES:
patent: 7511011 (2009-03-01), Curstedt et al.
patent: 2005/0176625 (2005-08-01), Curstedt et al.
patent: 2006/0205663 (2006-09-01), Johnson et al.
patent: 2008/0242589 (2008-10-01), Curstedt et al.
patent: 2009/0075892 (2009-03-01), Johansson et al.
patent: 2010/0004173 (2010-01-01), Johansson et al.
patent: 1 481 665 (2004-12-01), None
patent: 1 506 234 (2005-02-01), None
patent: 92/22315 (1992-12-01), None
patent: 00/47623 (2000-08-01), None
patent: 03/097695 (2003-11-01), None
patent: 2006/055532 (2006-05-01), None
Cochrane et al. Pulmonary Surfactant Protein B (SP-B): Structure-Function Relationships. Science. 1991. vol. 254, pp. 566-568.
Johansson, J., et al., “A Synthetic Surfactant Based on a Poly-Leu SP-C Analog and Phospholipids: Effects on Tidal Volumes and Lung Gas Volumes in Ventilated Immature Newborn Rabbits,” J. Appl. Physiol, vol. 95, Nov. 2003, pp. 2055-2063.
Davis, A. J., et al., “Lung Function in Premature Lambs and Rabbits Treated with a Recombinant SP-C Surfactant,” Am. J. Respir. Crit. Care Med., vol. 157, 1998, pp. 553-559.
U.S. Appl. No. 12/422,581, filed Apr. 13, 2009, Johansson, et al.
T. Curstedt et al.,Biology of the Neonate, vol. 87, pp. 332-337 (2005).
D. Wilson,Exp. Opin. Pharmacother., vol. 2 (9), pp. 1479-1493 (2001).
Survanta—beractant suspension, Abbott Laboratories, Inc. pp. 1-7.
Curstedt Tore
Johansson Jan
Robertson Bengt
Chiesi Farmaceutici S.p.A.
Cordero Garcia Marcela M
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Tsang Cecilia
LandOfFree
Reconstituted surfactants having improved properties does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reconstituted surfactants having improved properties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reconstituted surfactants having improved properties will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674675